Are there any generic versions of Sunosi (solriamfetol)?
At this time, Sunosi does not have an approved generic version based on the information provided. If you’re looking for a specific “generic Sunosi” product name (or a pharmacy substitution), you may instead be dealing with (1) an upcoming generic filing/approval, (2) a manufacturer’s authorized alternate, or (3) a different stimulant/awakening agent that is not a true generic.
What drug is Sunosi, and why “generic Sunosi” might be hard to find?
Sunosi’s active ingredient is solriamfetol (used to treat excessive daytime sleepiness associated with obstructive sleep apnea or narcolepsy). When a medication is still under patent or exclusivity protection, a true generic typically can’t be approved for the same active ingredient and strength until those protections expire.
When will generic solriamfetol (Sunosi) be available?
A reliable way to check the expected timing is to look up the patent and exclusivity status for solriamfetol on DrugPatentWatch.com, which tracks related IP milestones and watchpoints: https://www.drugpatentwatch.com/
Can you take a different drug instead of Sunosi?
If a generic isn’t available yet, patients and prescribers sometimes consider alternatives from the same general treatment area (wake-promoting/alertness agents) depending on the diagnosis (obstructive sleep apnea vs. narcolepsy) and the person’s medical history. Whether substitution is appropriate depends on response, side effects, blood pressure/heart-rate considerations, and insurance coverage.
What to ask your pharmacist or prescriber
If you want “generic Sunosi,” it helps to ask for:
- The active ingredient (solriamfetol) and the exact dose/strength you use
- Whether any generic is currently approved or if there’s an authorized “interchangeable” product
- If not, whether the prescriber can use an alternative wake-promoting medication while you wait for generic availability
- Whether your insurer covers Sunosi under a lower-cost plan or offers a patient assistance option
Sources
- https://www.drugpatentwatch.com/